Your browser doesn't support javascript.
loading
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors.
Belmontes, Brian; Sawant, Deepali V; Zhong, Wendy; Tan, Hong; Kaul, Anupurna; Aeffner, Famke; O'Brien, Sarah A; Chun, Matthew; Noubade, Rajkumar; Eng, Jason; Ma, Hayley; Muenz, Markus; Li, Peng; Alba, Benjamin M; Thomas, Melissa; Cook, Kevin; Wang, Xiaoting; DeVoss, Jason; Egen, Jackson G; Nolan-Stevaux, Olivier.
Afiliação
  • Belmontes B; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Sawant DV; Inflammation and Oncology Therapeutic Area, Amgen, Thousand Oaks, CA 91320, USA.
  • Zhong W; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Tan H; Inflammation and Oncology Therapeutic Area, Amgen, South San Francisco, CA 94080, USA.
  • Kaul A; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Aeffner F; Inflammation and Oncology Therapeutic Area, Amgen, South San Francisco, CA 94080, USA.
  • O'Brien SA; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Chun M; Inflammation and Oncology Therapeutic Area, Amgen, Thousand Oaks, CA 91320, USA.
  • Noubade R; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Eng J; Inflammation and Oncology Therapeutic Area, Amgen, South San Francisco, CA 94080, USA.
  • Ma H; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Muenz M; Translational Safety and Bioanalytical Sciences, Amgen, South San Francisco, CA 94080, USA.
  • Li P; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Alba BM; Inflammation and Oncology Therapeutic Area, Amgen, South San Francisco, CA 94080, USA.
  • Thomas M; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Cook K; Inflammation and Oncology Therapeutic Area, Amgen, South San Francisco, CA 94080, USA.
  • Wang X; Amgen Research, Thousand Oaks, CA 91320, USA.
  • DeVoss J; Inflammation and Oncology Therapeutic Area, Amgen, South San Francisco, CA 94080, USA.
  • Egen JG; Amgen Research, Thousand Oaks, CA 91320, USA.
  • Nolan-Stevaux O; Inflammation and Oncology Therapeutic Area, Amgen, South San Francisco, CA 94080, USA.
Sci Transl Med ; 13(608)2021 08 25.
Article em En | MEDLINE | ID: mdl-34433637

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article